• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2.全转录组分析表明聚(ADP-核糖)聚合酶1通过EZH2调节基因表达。
Mol Cell Biol. 2015 Dec;35(23):3934-44. doi: 10.1128/MCB.00635-15. Epub 2015 Sep 14.
2
Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.阴阳1介导的肿瘤抑制性微小RNA的表观遗传沉默激活肝细胞癌中的核因子κB
J Pathol. 2016 Apr;238(5):651-64. doi: 10.1002/path.4688.
3
Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.EZH2 通过增强子结合锌指蛋白 2 对人内皮细胞黏附和通讯的表观遗传调控。
Hypertension. 2012 Nov;60(5):1176-83. doi: 10.1161/HYPERTENSIONAHA.112.191098. Epub 2012 Sep 10.
4
PARP-2 regulates cell cycle-related genes through histone deacetylation and methylation independently of poly(ADP-ribosyl)ation.PARP-2 通过组蛋白去乙酰化和甲基化独立于多聚(ADP-核糖)化来调节细胞周期相关基因。
Biochem Biophys Res Commun. 2013 Feb 1;431(1):58-64. doi: 10.1016/j.bbrc.2012.12.092. Epub 2013 Jan 3.
5
Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons.Ezh1 和 Ezh2 对发育中的海马神经元中的 PSD-95 基因转录有差异调节作用。
Mol Cell Neurosci. 2013 Nov;57:130-43. doi: 10.1016/j.mcn.2013.07.012. Epub 2013 Aug 8.
6
Polycomb recruitment at the Class II transactivator gene.II类反式激活因子基因处的多梳蛋白招募
Mol Immunol. 2015 Oct;67(2 Pt B):482-91. doi: 10.1016/j.molimm.2015.08.003. Epub 2015 Aug 15.
7
Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.多发性骨髓瘤中组蛋白H3赖氨酸27和赖氨酸4三甲基化的全基因组分析揭示了多梳基因靶向的重要性,并突出了EZH2作为潜在治疗靶点的地位。
Oncotarget. 2016 Feb 9;7(6):6809-23. doi: 10.18632/oncotarget.6843.
8
A new kinetochore component CENP-W interacts with the polycomb-group protein EZH2 to promote gene silencing.一种新的动粒成分CENP-W与多梳蛋白家族蛋白EZH2相互作用以促进基因沉默。
Biochem Biophys Res Commun. 2015 Aug 14;464(1):256-62. doi: 10.1016/j.bbrc.2015.06.136. Epub 2015 Jun 23.
9
Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells.四跨膜蛋白家族成员CD82通过使白血病细胞中的p38丝裂原活化蛋白激酶信号失活来调节EZH2的表达。
PLoS One. 2015 May 8;10(5):e0125017. doi: 10.1371/journal.pone.0125017. eCollection 2015.
10
The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.转录抑制因子NIPP1是EZH2介导的基因沉默中的关键因子。
Oncogene. 2008 Feb 28;27(10):1449-60. doi: 10.1038/sj.onc.1210774. Epub 2007 Sep 3.

引用本文的文献

1
Transcriptional regulation mechanism of PARP1 and its application in disease treatment.PARP1 的转录调控机制及其在疾病治疗中的应用。
Epigenetics Chromatin. 2024 Aug 8;17(1):26. doi: 10.1186/s13072-024-00550-w.
2
Targeting latent viral infection in EBV-associated lymphomas.针对EB病毒相关淋巴瘤中的潜伏性病毒感染。
Front Immunol. 2024 Feb 23;15:1342455. doi: 10.3389/fimmu.2024.1342455. eCollection 2024.
3
PARP1 as an Epigenetic Modulator: Implications for the Regulation of Host-Viral Dynamics.聚(ADP-核糖)聚合酶1作为一种表观遗传调节剂:对宿主-病毒动态调节的影响
Pathogens. 2024 Jan 30;13(2):131. doi: 10.3390/pathogens13020131.
4
Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges.PARP和EZH2联合抑制用于癌症治疗:现状、机遇与挑战
Front Pharmacol. 2022 Oct 3;13:965244. doi: 10.3389/fphar.2022.965244. eCollection 2022.
5
Role of NAD and FAD in Ischemic Stroke Pathophysiology: An Epigenetic Nexus and Expanding Therapeutic Repertoire.NAD 和 FAD 在缺血性中风病理生理学中的作用:一个表观遗传学枢纽和不断扩大的治疗谱。
Cell Mol Neurobiol. 2023 Jul;43(5):1719-1768. doi: 10.1007/s10571-022-01287-4. Epub 2022 Sep 30.
6
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system.提高PARP抑制剂在高级别浆液性卵巢癌中的疗效:聚焦免疫系统。
Front Genet. 2022 Sep 9;13:886170. doi: 10.3389/fgene.2022.886170. eCollection 2022.
7
Human PARP1 Facilitates Transcription through a Nucleosome and Histone Displacement by Pol II In Vitro.人类 PARP1 通过 Pol II 在体外促进核小体和组蛋白的转录位移。
Int J Mol Sci. 2022 Jun 26;23(13):7107. doi: 10.3390/ijms23137107.
8
Neuroprotective Effects of PARP Inhibitors in Models of Alzheimer's Disease.聚腺苷二磷酸核糖聚合酶抑制剂在阿尔茨海默病模型中的神经保护作用。
Cells. 2022 Apr 9;11(8):1284. doi: 10.3390/cells11081284.
9
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.聚腺苷二磷酸核糖聚合酶 1 作为急性髓细胞白血病和骨髓增生异常综合征的治疗靶点。
Blood Adv. 2021 Nov 23;5(22):4794-4805. doi: 10.1182/bloodadvances.2021004638.
10
PARP1-modulated chromatin remodeling is a new target for cancer treatment.PARP1 调节的染色质重塑是癌症治疗的新靶点。
Med Oncol. 2021 Aug 25;38(10):118. doi: 10.1007/s12032-021-01570-2.

本文引用的文献

1
ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation.ARTD1通过抑制依赖MLL1的组蛋白H3三甲基化来抑制白细胞介素6的表达。
Mol Cell Biol. 2015 Sep;35(18):3189-99. doi: 10.1128/MCB.00196-15. Epub 2015 Jul 6.
2
A Systematic Analysis of Factors Localized to Damaged Chromatin Reveals PARP-Dependent Recruitment of Transcription Factors.对定位于受损染色质的因素进行的系统分析揭示了转录因子的PARP依赖性募集。
Cell Rep. 2015 Jun 9;11(9):1486-500. doi: 10.1016/j.celrep.2015.04.053. Epub 2015 May 21.
3
ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells.ADP核糖基转移酶Parp1和Parp7可维护胚胎干细胞的多能性。
Nucleic Acids Res. 2014 Aug;42(14):8914-27. doi: 10.1093/nar/gku591. Epub 2014 Jul 17.
4
Poly(ADP-ribose) polymerase 1 (PARP1) associates with E3 ubiquitin-protein ligase UHRF1 and modulates UHRF1 biological functions.聚(ADP-核糖)聚合酶 1(PARP1)与 E3 泛素蛋白连接酶 UHRF1 相关联,并调节 UHRF1 的生物学功能。
J Biol Chem. 2014 Jun 6;289(23):16223-38. doi: 10.1074/jbc.M113.527424. Epub 2014 Apr 29.
5
EZH2 in normal and malignant hematopoiesis.EZH2 在正常和恶性造血中的作用。
Leukemia. 2014 Jan;28(1):44-9. doi: 10.1038/leu.2013.288. Epub 2013 Oct 7.
6
BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.BMN 673,一种新型高效的 PARP1/2 抑制剂,用于治疗具有 DNA 修复缺陷的人类癌症。
Clin Cancer Res. 2013 Sep 15;19(18):5003-15. doi: 10.1158/1078-0432.CCR-13-1391. Epub 2013 Jul 23.
7
The expanding role of PARPs in the establishment and maintenance of heterochromatin.PARPs 在异染色质的建立和维持中的作用不断扩大。
FEBS J. 2013 Aug;280(15):3508-18. doi: 10.1111/febs.12368. Epub 2013 Jun 27.
8
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.EZH2 对于生发中心的形成是必需的,并且体细胞 EZH2 突变促进淋巴样转化。
Cancer Cell. 2013 May 13;23(5):677-92. doi: 10.1016/j.ccr.2013.04.011.
9
Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.奥拉帕利的药效动力学和药代动力学评价:计划择期行乳腺癌手术患者的 I 期多中心试验。
Invest New Drugs. 2013 Aug;31(4):949-58. doi: 10.1007/s10637-012-9922-7. Epub 2013 Jan 13.
10
A complex Polycomb issue: the two faces of EZH2 in cancer.一个复杂的 Polycomb 问题:EZH2 在癌症中的双重面目。
Genes Dev. 2012 Apr 15;26(8):751-5. doi: 10.1101/gad.191163.112.

全转录组分析表明聚(ADP-核糖)聚合酶1通过EZH2调节基因表达。

Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2.

作者信息

Martin Kayla A, Cesaroni Matteo, Denny Michael F, Lupey Lena N, Tempera Italo

机构信息

Fels Institute for Cancer and Molecular Biology, Temple University, Philadelphia, Pennsylvania, USA.

Section of Rheumatology, Temple University, Philadelphia, Pennsylvania, USA Department of Microbiology and Immunology, Temple University, Philadelphia, Pennsylvania, USA.

出版信息

Mol Cell Biol. 2015 Dec;35(23):3934-44. doi: 10.1128/MCB.00635-15. Epub 2015 Sep 14.

DOI:10.1128/MCB.00635-15
PMID:26370511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4628063/
Abstract

Posttranslational modifications, such as poly(ADP-ribosyl)ation (PARylation), regulate chromatin-modifying enzymes, ultimately affecting gene expression. This study explores the role of poly(ADP-ribose) polymerase (PARP) on global gene expression in a lymphoblastoid B cell line. We found that inhibition of PARP catalytic activity with olaparib resulted in global gene deregulation, affecting approximately 11% of the genes expressed. Gene ontology analysis revealed that PARP could exert these effects through transcription factors and chromatin-remodeling enzymes, including the polycomb repressive complex 2 (PRC2) member EZH2. EZH2 mediates the trimethylation of histone H3 at lysine 27 (H3K27me3), a modification associated with chromatin compaction and gene silencing. Both pharmacological inhibition of PARP and knockdown of PARP1 induced the expression of EZH2, which resulted in increased global H3K27me3. Chromatin immunoprecipitation confirmed that PARP1 inhibition led to H3K27me3 deposition at EZH2 target genes, which resulted in gene silencing. Moreover, increased EZH2 expression is attributed to the loss of the occupancy of the transcription repressor E2F4 at the EZH2 promoter following PARP inhibition. Together, these data show that PARP plays an important role in global gene regulation and identifies for the first time a direct role of PARP1 in regulating the expression and function of EZH2.

摘要

翻译后修饰,如多聚(ADP-核糖)化(PARylation),可调节染色质修饰酶,最终影响基因表达。本研究探讨了多聚(ADP-核糖)聚合酶(PARP)在淋巴母细胞B细胞系中对全局基因表达的作用。我们发现,用奥拉帕利抑制PARP催化活性会导致全局基因失调,影响约11%的表达基因。基因本体分析表明,PARP可通过转录因子和染色质重塑酶发挥这些作用,包括多梳抑制复合物2(PRC2)成员EZH2。EZH2介导组蛋白H3赖氨酸27位点的三甲基化(H3K27me3),这种修饰与染色质压缩和基因沉默相关。PARP的药理抑制和PARP1的敲低均诱导了EZH2的表达,导致全局H3K27me3增加。染色质免疫沉淀证实,PARP1抑制导致EZH2靶基因处H3K27me3沉积,从而导致基因沉默。此外,PARP抑制后,转录抑制因子E2F4在EZH2启动子上的占据缺失导致EZH2表达增加。总之,这些数据表明PARP在全局基因调控中起重要作用,并首次确定了PARP1在调节EZH2表达和功能方面的直接作用。